Recent Publications

Phung, T. A. T., Weng, R., Black, P. C., Dyrskjøt, L., de Jong, J. J., & Gibb, E. A. (2026). A Long Noncoding RNA–based Classifier for Identifying More Aggressive Low-grade Ta Bladder Cancer with Elevated FGFR3 Activity. European Urology Oncology.

de Jong, J. J., Reike, M. J., Lotan, Y., Seiler, R., Davicioni, E., Necchi, A., … & Gibb, E. A. (2025). Molecular Characterization of Residual Muscle-Invasive Bladder Cancer Identifies a Scar-Like Transcriptomic Profile with Favorable Prognosis after Neoadjuvant Therapy. Clinical Cancer Research, 31(19), 4174–4183.

de Jong, J. J., Black, P. C., Dyrskjøt, L., & Gibb, E. A. (2025). Long Noncoding RNAs Identify a Subgroup of Patients with Low-grade Non–muscle-invasive Bladder Cancer with Less Favorable Outcomes. European Urology Oncology, 8(4), 879–882.

Weng, R., Phung, T. A. T., Bell, R., Dyrskjøt, L., & Gibb, E. A. (2025). Long non-coding RNAs define favourable biology in high-risk non-muscle-invasive bladder cancer. BJUI Compass, 6(12), e70131.